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Background: The quaternary organization of G protein-coupled receptors remains a subject of considerable debate.
Results: The serotonin 5-HT2C receptor is a mixture of monomers, dimers, and higher-order oligomers. These become pre-
dominantly monomers upon antagonist treatment.
Conclusion: SpIDA indicates that the 5-HT2C receptor exists as mixtures of forms that are regulated in an antagonist-depen-
dent manner.
Significance: SpIDA delivers new insights into receptor quaternary structure.
The questions of whether G protein-coupled receptors exist
as monomers, dimers, and/or oligomers and if these species
interconvert in a ligand-dependentmanner are among themost
contentious current issues in biology. When employing spatial
intensity distribution analysis to laser scanning confocal micro-
scope images of cells stably expressing either a plasma mem-
brane-associated form of monomeric enhanced green fluores-
cent protein (eGFP) or a tandem version of this fluorophore, the
eGFP tandem was identified as a dimer. Similar studies on cells
stably expressing an eGFP-tagged form of the epidermal growth
factor receptor demonstrated that, although largely a monomer
in the basal state, this receptor rapidly became predominantly
dimeric upon the addition of its ligand epidermal growth factor.
In cells induced to express an eGFP-tagged form of the sero-
tonin 5-hydroxytryptamine 2C (5-HT2C) receptor, global analy-
sis of construct quantal brightness was consistent with the pre-
dominant formof the receptor being dimeric.However, detailed
spatial intensity distribution analysis demonstrated the pres-
ence ofmultiple forms ranging frommonomers to higher-order
oligomers. Furthermore, treatment with chemically distinct
5-HT2C receptor antagonists resulted in a time-dependent
change in the quaternary organization to one inwhich therewas
a preponderance of receptor monomers. This antagonist-medi-
ated effect was reversible, because washout of the ligand
resulted in the regeneration of many of the oligomeric forms of
the receptor.
Defining the quaternary organization of protein complexes
without resorting to cellular disruption followed by biochemi-
cal analysis remains a major challenge. Resonance Energy
Transfer (RET)3 techniques, including various forms of fluores-
cence resonance energy transfer (FRET), are well established
approaches that can identify protein-protein interactions in
intact cells (1–4). However, such approaches are generally
unable to also identify co-expressedmonomeric species.More-
over, although it is conceptually possible to discriminate
between dimeric and higher-order complexes, it is often diffi-
cult, in practice, to discriminate between such forms in RET-
based studies. Furthermore, with expression to high levels of
proteins containing suitable fluorophores, RET signals that
reflect crowding or random “bystander” effects are often diffi-
cult to resolve from true signals that reflect direct interactions
between the proteins being studied. Conversely, the absence of
RET signals does not necessarily mean the absence of protein-
protein interaction and could simply reflect the incapacity of
the constructs to transfer energy (e.g. large distance between or
orientation of the fluorophores) or, similarly, the presence of
another binding partner between the two studied proteins.
The structural organization of certain transmembrane
receptor families (e.g. the broad group of single transmembrane
domain receptor tyrosine kinases) is well established, as is the
basic concept that ligand binding to many of these receptors
results in their dimerization to promote signal transduction
(5–7). However, for many other transmembrane receptor
classes, there is substantially less clarity on these matters. Spa-
tial intensity distribution analysis (SpIDA) directly measures
fluorescent macromolecule densities and oligomerization
states sampledwithin single images (8). Themethod is based on
fitting intensity histograms calculated from images to obtain
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densitymaps of fluorescentmolecules and their quantal bright-
ness (QB) (9). SpIDA has recently begun to be employed to
determine both basal organization and also changes in such
organization in response to activation of a number of trans-
membrane receptors (10–11). Indeed, in some of the initial
applications of SpIDA, the proportion of epidermal growth fac-
tor receptor (EGFR) present as dimer was shown to increase in
response to the addition of the ligand EGF, whereas that of
monomer decreased (8). In contrast, the single transmembrane
domain axonal guidance receptor Robo-1 has been shown to be
a constitutive dimer in the basal state, and this was unaffected
by the addition of the ligand Slit 2 (12).
One of the most actively studied groups of transmembrane
receptors is the seven-transmembrane domain G protein-cou-
pled receptor (GPCR) family. This reflects both their prepon-
derance in number and their targeting by a host of therapeutic
medicines. Although it is well established that members of the
small, class C or “glutamate-like” receptor grouping are consti-
tutive dimers (13, 14) or possibly dimers of dimers (15), under-
standing of the quaternary organization of the much larger
group of class A or “rhodopsin-like” receptors lags substantially
behind (16). Although highly studied, this is one of the most
contentious areas in current biology with very different conclu-
sions being reached. These range from opinions that consider
most of the receptor population to exist as monomer, with only
random collisions suggesting quaternary structure (17–21), to
others that indicate the vastmajority, or even all, of the receptor
exists as either dimers or higher-order oligomers (22–25). The
implications of such organization for both novel drug design
and understanding of the mode of action of current medicines
(26, 27) are also an actively debated topic. Herein, we have
employed SpIDA to address this question for the 5-HT2C recep-
tor, a class AGPCR that responds to the neurotransmitter sero-
tonin. Prior to performing such studies, a series of control
experiments were performed. First, enhancedGFP (eGFP) con-
taining the A206K mutation that limits the tendency of this
protein to self-associate (28) or a tandem of this fluorophore
was attached to the plasma membrane of transfected cells by
the addition of a myristoylation and palmitoylation consensus
sequence (29). Analysis by SpIDA demonstrated that the
A206K eGFP tandem was recorded as a dimer compared with
the single molecule of A206K eGFP. Furthermore, over a broad
range of expression levels, a single molecule of plasma mem-
brane-associated A206K eGFP was reported consistently as
monomeric. Subsequently, by linkingA206K eGFP to the single
transmembrane domain EGFR, the addition of the ligand EGF
was shown to convert a large proportion of the receptor from
monomer to dimer. When expanded to the 5-HT2C receptor,
this GPCR was shown to exist at the basolateral plasma mem-
brane of cells stably expressing this receptor in forms ranging
from monomer to higher-order oligomers. Treatment with a
number of antagonists of the 5-HT2C receptor (reversibly)
reduced this complexity to favormonomeric and dimeric forms
of the receptor. These results demonstrate that this receptor
can exist in multiple forms, that interaction with ligands can
alter this ensemble substantially, and that methods that report
averages of receptor organizational structure fail to identify the
level of complexity present.
EXPERIMENTAL PROCEDURES
Materials—General laboratory chemicals were from Sigma-
Aldrich (Poole, UK) or Fisher Scientific (Leicester, UK). Other-
wise, DNA restriction endonucleases, calf intestinal alkaline
phosphatase, T4 DNA polymerase, and T4 ligase were from
NewEngland Biolabs (Hitchin, UK). TheWizard Plus SVMini-
prep kit was fromPromega (Southampton, UK).NuPageNovex
precast 4–12%BisTris gels,NuPageMOPSSDS running buffer,
and native polyacrylamide gels and their associated buffers,
markers, and sample preparation reagents were from Invitro-
gen (Paisley, UK). The QIAfilter Plasmid Maxi Kit, PCR purifi-
cation kit, and QIAquick gel extraction kit were from Qiagen
(Crawley, UK). Agarose was from Flowgen Biosciences (Not-
tingham, UK). Secondary horseradish peroxidase-conjugated
antibody was from Sigma-Aldrich. ECL reagent was purchased
from Pierce (Tattenhall, UK). Polyethylenimine (PEI) was from
Polysciences Inc. (Warrington, PA). [3H]Mesulergine was from
PerkinElmer Life Sciences (Chalfont Road, UK). Serotonin
hydrochloride (5-HT) was from Sigma-Aldrich. SB242084
(6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)-
oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride),
SB243213 (2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)-
oxy]-3-pyridinyl]-6-(trifluoromethyl)-1H-indole-1-carboxamide
dihydrochloride), and RS102221 (8-[5-(2,4-dimethoxy-5-(4-tri-
fluoromethylphenylsulfonamido)phenyl-5-oxopentyl]-1,3,8-tri-
azaspiro[4.5]decane-2,4-dione hydrochloride) were from
Tocris Bioscience (Abingdon, UK).
DNA Constructs—Constructs expressing a single enhanced
(1x) green fluorescent protein, tandem (2x) eGFPs, and the
human 5-HT2C receptor fused at its carboxyl terminus to eGFP
(5-HT2C-eGFP) were a gift of Dr. K. Herrick-Davis (Albany,
NY). These constructs were all based upon the vector pEG-
FPN1 (Clontech), and all had been modified to incorporate an
A206K mutation in the eGFP to reduce any tendency for the
fluorescent protein to homodimerize (28). In order to localize
the 1x-A206K eGFP and 2x-A206K eGFP to the plasma mem-
brane, a palmitoylation-myristoylation sequence was added to
the amino terminus of the fluorescent protein(s) by subcloning
the following oligonucleotides between theNheI and BglII sites
of the pEGFPN-1 polylinker after annealing them together:
oligo 1, CTAGCGCCACCATGGGATGCATCAACTCGAA-
GAGAAAGGATA; oligo 2, GATCTATCCTTTCTCTTC-
GAGTTGATGCATCCCATGGTGGCG. This added the fol-
lowing palmitoylation-myristoylation sequence to the amino
terminus: Met-Gly-Cys-Ile-Asn-Ser-Lys-Arg-Lys-Asp (29)
(Fig. 1A). The EGFR was fused to A206K eGFP at the carboxyl
terminus by subcloning PCR-amplified EGFR into pEGFPN1 at
AscI and NotI (which were added to the vector by inserting a
suitable linker).
To make inducible Flp-InTM T-RExTM stable cell lines,
the palmitoylation-myristoylation-A206K eGFP (P-M-A206K
eGFP), palmitoylation-myristoylation-2xA206K eGFP (P-M-
2xA206K eGFP), and 5-HT2C-A206K eGFP were excised with
NheI and NotI and subcloned into the pcDNA5/FRT/TO vec-
tor at EcoRV-Not1 (after blunting the NheI site). The pcDNA5
EGFR-A206K eGFP construct was made by a similar strategy
except that it had to be assembled as a three-way ligation due to
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the presence of a NotI site at the fusion junction. All constructs
were verified by sequencing.
Cell Lines—All cells weremaintained in a humidified incuba-
torwith 95%air and 5%CO2 at 37 °C.Human embryonic kidney
cells (HEK293T) were grown as a monolayer in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10%
(v/v) fetal bovine serum, 2mML-glutamine, 100 unitsml1 pen-
icillin, and 0.1 mgml1 streptomycin. Parental Flp-InTM
T-RExTM 293 cells (Invitrogen) were maintained in DMEM
(high glucose) supplementedwith 10% (v/v) fetal bovine serum,
2 mM L-glutamine, 100 unitsml1 penicillin, 0.1 mgml1
streptomycin, and 100 gml1 zeocin. Cell lines generated
using Flp-InTM T-RExTM 293 cells as the base were maintained
in DMEM (high glucose) supplemented with 10% (v/v) fetal
bovine serum, 2 mM L-glutamine, 100 unitsml1 penicillin,
0.1 mgml1 streptomycin, 10 gml1 blasticidin, and 200
gml1 hygromycin.
Stable Cell Line Generation—Flp-InTM T-RExTM 293 cells
were transfected with a mixture of pcDNA5/FRT/TO vector
(harboring 5-HT2C-A206K eGFP, P-M-A206K eGFP, P-M-
2xA206K eGFP, or EGFR-A206K eGFP) and the pOG44 plas-
mid in a 1:9 ratio with PEI (30). After 48 h, the medium was
changed tomedium supplementedwith 200gml1 hygromy-
cin to initiate selection of stably transfected cells. Pools of cells
were established (10–14 days for resistant colonies to form)
and tested for inducible expression by the addition of 1gml1
doxycycline for 48 h followed by screening for fluorescence
corresponding to A206K eGFP and for fused A206K eGFP
expression by Western blotting.
Generation of Cell Lysates and Western Blotting—Cells were
washed once in cold PBS (120 mM NaCl, 25 mM KCl, 10 mM
Na2HPO4, and 3 mM KH2PO4, pH 7.4) and harvested with ice-
cold radioimmunoprecipitation assay buffer (50 mM HEPES,
150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 10
mMNaF, 5mMEDTA, 10mMNaH2PO4, 5% ethylene glycol, pH
7.4) supplemented with Complete protease inhibitor mixture
(Roche Diagnostics, Mannheim, Germany). Extracts were
passed through a 25-gauge needle and incubated for 15 min at
4 °C while on a rotating wheel. Cellular extracts were then cen-
trifuged for 30 min at 21,000  g, and the supernatant was
recovered. Samples were prepared by the addition of SDS-
PAGE sample buffer and heated to 65 °C for 5min before being
subjected to SDS-PAGE analysis using 4–12% BisTris gels
(NuPAGE; Invitrogen) and MOPS buffer. After separation, the
proteins were electrophoretically transferred to nitrocellulose
membrane, whichwas then blocked (5% fat-freemilk powder in
PBSwith 0.1%Tween 20) at 4 °C on a rotating shaker overnight.
The membrane was incubated for 3 h with primary antibody
(1:20,000 sheep anti-GFP) in 2% fat-free milk powder in PBS-
Tween, washed (3  10 min PBS-Tween), and then incubated
for 3 h with appropriate secondary antibody (horseradish per-
oxidase-linked rabbit anti-goat IgG, Sigma-Aldrich) diluted
1:10,000 in 2% fat-freemilk powder in PBS-Tween. After wash-
ing, proteins were detected by enhanced chemiluminescence
(Pierce) according to the manufacturer’s instructions.
Cell Membrane Preparation—Cells induced with the
required concentration of doxycycline to express 5-HT2C-
A206K eGFP or other constructs were washed and then har-
vested with ice-cold PBS. Pellets of cells were frozen at80 °C
for a minimum of 1 h, thawed, and resuspended in ice-cold 10
mM Tris-HCl, 0.1 mM EDTA, pH 7.4 (TE buffer) supplemented
with Complete protease inhibitor mixture. Cells were homog-
enized on ice by 40 strokes of a glass-on-Teflon homogenizer
followed by centrifugation at 1000  g for 5 min at 4 °C to
remove unbroken cells and nuclei. The supernatant fraction
was removed and passed through a 25-gauge needle 10 times
before being transferred to ultracentrifuge tubes and subjected
to centrifugation at 90,000 g for 30 min at 4 °C. The resulting
pellets were resuspended in ice-cold TE buffer. Protein concen-
tration was assessed, and membranes were stored at 80 °C
until required.
[3H]Mesulergine Binding Assays—Saturation binding curves
were established by the addition of 20 g of membrane protein
to assay buffer (50 mM Tris-HCl, 100 mM NaCl, and 3 mM
MgCl2, pH 7.5) containing varying concentrations of [3H]me-
sulergine (0.5–30 nM). Nonspecific binding was determined in
the presence of 10 Mmianserin. Reactions were incubated for
60 min at 25 °C, and bound ligand was separated from free by
vacuum filtration through GF/C filters (Brandel Inc., Gaithers-
burg, MD) that had been presoaked in 50mMTris-HCl, pH 7.5,
0.5% poly(ethyleneimine) (50% solution; P3143, Sigma). The
filters were washed twice with cold 50 mM Tris-HCl, pH 7.5,
and bound ligand was estimated by liquid scintillation spec-
trometry. Competition binding assays were carried out in a
similar way but with a constant concentration of [3H]mesul-
ergine (5 nM) and the addition of a range of concentrations of
ligands of interest (0.03 nM to 10M). Data were analyzed using
GraphPad Prism version 5.03 (GraphPad Inc.).
Calcium Mobilization Assays—Flp-InTM T-RExTM 293 cells
able to express the 5-HT2C-A206K eGFP construct in an induc-
ible manner were seeded into poly-D-lysine-coated, black, clear
bottom 96-well microtiter plates at 50,000 cells/well for use
48 h later. 24 h after construct induction with doxycycline, the
cells were loaded with the calcium-sensitive dye Fura-2, by
exchanging the medium for DMEM containing 3 M Fura-
2AM. The plates were incubated in the dark for 45min at 37 °C
and then washed with 2  100 l/well HEPES buffer (130 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mMMgCl2, 20 mMHEPES, and
10 mM D-glucose, pH 7.4). 100 l/well HEPES buffer was then
added, and the plate was incubated at room temperature for 45
min in the dark. The effect of ligands was then assessed by
measuring changes in Fura-2 ratio in response to calciummobi-
lization using a FLEX-Station (Molecular Devices, Sunnydale,
CA). Data were analyzed using GraphPad Prism version 5.03.
Native Blue Polyacrylamide Gel Electrophoresis—Flp-InTM
T-RExTM 293 cells induced with doxycycline to express EGFR-
A206K eGFP, with or without treatment with EGF, were har-
vested in 1 PBS and lysed in lysis buffer (150 mM NaCl, 0.01
mM Na3PO4, 2 mM EDTA, 0.5% n-dodecyl -D-maltoside, and
5% glycerol plus protease inhibitormixture tablets, pH 7.4) on a
rotating wheel for 30 min at 4 °C. Samples were then centri-
fuged for 30 min at 100,000  g at 4 °C, and the supernatants
were collected. 18 g of solubilized supernatant plus 4 l of
G250 additive (Invitrogen) was loaded on to each lane of
NativePAGETM Novex 3–12% BisTris gels (Invitrogen). In
some samples (as indicated), SDS was added 10 min prior to
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loading. After migration at room temperature (using buffers
and conditions indicated by the manufacturer), proteins were
transferred (90 min at 25 V) onto a PVDF membrane that had
been prewetted for 30 s in methanol. The membrane was then
fixed in 8% acetic acid for 15 min and immunoblotted with
anti-GFP antiserum as described above.
Spatial Intensity Distribution Analysis—Flp-InTM T-RExTM
293 cells harboring the requiredA206K eGFP-tagged construct
were plated down onto poly-D-lysine-coated 30-mm glass cov-
erslips at a density of 2.5  105 cells/coverslip. These were
allowed to grow overnight and were then induced using doxy-
cycline (concentrations as described throughout). The cells
were allowed to grow overnight, and the coverslips were then
rinsed in six changes ofHEPES buffer (130mMNaCl, 5mMKCl,
1mMCaCl2, 1mMMgCl2, 20mMHEPES, and 10mMD-glucose,
pH 7.4), and confocal microscope images were collected. Imag-
ing was carried out using a Zeiss LSM 5 PASCAL EXCITER
laser scanning head coupled to a Zeiss Axiovert 200M inverted
microscope equipped with a63 plan apochromat oil immer-
sion lens with a numerical aperture of 1.4. All samples were
excited using the 488-nm line of the 25-milliwatt multiargon
laser. 1024  1024 images were acquired using a pixel dwell
time of 12.8 s/pixel and pixel size of 0.06 or 0.09 m. Detec-
tion was by a photomultiplier tube (PMT) using the following
parameter settings: gain 850 V, offset 0, amplifier gain 1.
Pinhole was set to 1.00 airy unit 96m. The secondary beam
splitter NFT490 together with the emission filter 505LP were
chosen to efficiently collect the A206K eGFP emission signal in
channel 1. Laser intensity and PMT gain were chosen to mini-
mize photobleaching and pixel saturation. To perform SpIDA
analysis, it was also necessary to determine the 488-nm laser
beam waist radius size, PMT shot noise, and white noise back-
ground signal. The laser beam waist radius size was estimated
by imaging a z stack of subdiffraction-sized 100-nmTetraspeck
fluorescent microspheres (Invitrogen, catalog no. T14792).
This z stack was imported into ImageJ, and theMetroloJ plugin
was used to quantify x, y, and z point spread function values,
which equated to 0.3156m for x and y and 0.6929m for z. 50
nm was removed from each of these values, and the laser beam
waist area was quantified by squaring the 0.2656 m value and
multiplying it by , which equated to a beam waist area of
0.2215 m2. PMT shot noise was measured by laser spot scan-
ning the surface of a mirror slide in the plane of focus of the
microscope. The resulting reflected signal (when the 488-nm
laser line was switched on) provided uniform illumination of
the detector. Spot mode fluctuation signals were recorded for
30 s using a range of different laser powers until the signal
saturated the PMT detector. The mean variance (standard
deviation squared) of the fluctuation signals was plotted as a
function of the laser intensity and the slope value calculated for
the linear part of the plot. The calculated slope value defines the
limit for the maximum intensity that can be analyzed using the
SpIDA software. A slope value of 37.49  0.081 intensity units
(IU) (PMTshot noise)was applied to all image sets loaded into the
SpIDA program. The white noise background signal was deter-
mined by measuring the pixel intensity values for an image
acquired when the 488-nm laser line was switched off. SpIDA
analysis was performed using a stand-alone MATLAB Graphical
User Interface program, available at theNeurophotonicsWeb site
(8). Images were imported into the SpIDA software, and the laser
beamwaist size and image pixel size were input.
The fitting of super-Poissonian distribution curves to fluo-
rescence intensity histogram plots created from carefully
selected regions of interest (RoIs) (to obtain good super-Pois-
sonian fitting, fluorescent moieties defined within the analysis
RoIsmust have a homogeneous distribution) was performed on
the imported input image using the SpIDA software. This forms
the basis of SpIDA measurement of both quantal brightness
(QB) and the number of fluorescent moieties per beam area
(density) within the analyzed RoI. QB was defined as the aver-
age intensity units over time/beam waist area for each fluores-
cent entity investigated (monomers to higher-order oligomers).
The super-Poissonian fitting procedure times varied from 1 to
5 s, depending on the population model and bin size used. The
RoI sizes used contained at least 88.4–195.7 beam areas, which
equates to a pixel RoI size measurement of 40 40 to 60 60.
The size of the RoI plotted on each analyzed cell was dependent
upon the homogeneous area available, and only one RoI was
drawn on each cell analyzed. The number of cells analyzed for
each experimental group ranged from 44 to 65, and number of
individual images analyzed was between 15 and 20 images.
For the initial determination of the QB value of monomeric
P-M-A206K eGFP, the program was used in the one-popula-
tion mode, obtaining a value of (12.71  0.29 IU). Subsequent
measurements using the receptor-eGFP constructs used the
one- or two-population fit model modes with the previously
determined QB value of 12.71 IU. SpIDA monomer to dimer
oligomeric analysis of the EGFR-A206K eGFP-expressing cells
in response to epidermal growth factor treatment was quanti-
fied specifically using the two-population monomer-dimer
model. Due to the oligomerization state complexity of the
5-HT2C-A206K eGFP receptor (i.e. initial analysis indicated
that there were more than two populations present, so none of
the two-population fit models could be used to yield accurate
quantification), we used the one-population SpIDA model,
which can accurately quantify average QB and density values in
the presence of higher-order oligomeric populations.4 Using
one-population SpIDA, the quantified QB value of monomeric
P-M-A206K eGFPwas used to quantify the oligomeric status of
the 5-HT2C-A206K eGFP receptor. The SpIDA software also
reports the mean fluorescent intensity for each RoI analyzed.
The number of 5-HT2C-A206K eGFP receptors per m2 (den-
sity) was measured by dividing this mean fluorescent intensity
by the quantified monomeric QB value. Differences between
the mean values of each experimental group data set were sta-
tistically quantified using one-way analysis of variance
(GraphPad Prism version 5).
RESULTS
Determination of the Quantal Brightness ofMembrane-local-
ized A206K eGFP—SpIDA can be used to assess the oligomeric
size of complexes of a protein tagged with an appropriate fluo-
rophore, such as monomeric A206K eGFP, at various locations
in a cell by statistical analysis of suitable laser confocal scanning
4 A. G. Godin, unpublished observations.
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images (8). We have previously expressed transiently in
HEK293T cells either monomeric A206K eGFP or a tandem of
this protein in which the two copies of the fluorescent polypep-
tide were linked by a short peptide sequence (Arg-Ile-Leu-Gln-
Ser-Thr-Val-Pro-Arg-Ala-Arg-Asp-Pro-Pro-Val-Asp-Ile).
RoIswithin the cytoplasmwhere, as soluble proteins, these con-
structs were locatedwere then imaged. Analysis of QB, which is
proportional to the number of photons emitted by a fluorescent
entity and hence to its oligomeric state, demonstrated the
A206K eGFP tandem to have twice the value of the monomer
(12). To generate suitable control experiments for subsequent
studies on plasma membrane-associated or transmembrane
proteins, we added a plasma membrane-targeting, palmitoyla-
tion-myristoylation sequence, (Met)-Gly-Cys-Ile-Asn-Ser-
Lys-Arg-Lys-Asp (29), at the amino terminus of A206K eGFP
and also to the tandem of A206K eGFPs. As anticipated, both
following transient expression in HEK293T cells (data not
shown) and following doxycycline-induced expression from
the Flp-InTM T-RExTM locus of stably transfected Flp-InTM
T-RExTM 293 cell lines, each of these constructs was targeted
effectively to the plasma membrane (Fig. 1A). Such cells were
treatedwith varying concentrations (0.25–100ngml1, 24 h) of
doxycycline to induce expression of these constructs to differ-
ent levels. Over this concentration range of the inducer, immu-
noblotting studies using an anti-GFP antiserum indicated
substantial increases in the amount of the palmitoylation-myr-
istoylation-modified forms of both A206K eGFP and the tan-
dem of this fluorophore (Fig. 1B). Moreover, the apparent
molecular mass of the predominant form of each construct, 30
kDa for the single eGFP and 60 kDa for the tandem construct,
was as anticipated (Fig. 1B). Laser scanning confocal images of
the basolateral membrane of such cells were collected (Fig. 1C).
Analysis of individual RoIs from cells expressing either the
palmitoylation-myristoylation-linked A206K eGFP construct
(Fig. 2A) or the palmitoylation-myristoylation-linked A206K
eGFP tandem (Fig. 2B) demonstrated an excellent data fit to the
theory. Across a range of construct expression levels, analysis of
images of the RoIs within the surface of cells expressing the
palmitoylation-myristoylation-linked A206K eGFP construct
indicated that QB values were statistically not different (Fig.
2C) with, across the full data set, a value of 12.71  0.29 IU
(mean  S.E., n  220). Analysis of images taken from cells
expressing varying amounts of the palmitoylation-myristoyla-
tion-linked A206K eGFP tandem also indicated that QB values
were statistically not different across the range of expression
levels achieved (Fig. 2D). However, now QB values across the
full data set, 24.98  0.53 IU (mean  S.E., n  220), were
almost exactly twice (1.97 0.04 times) those of the palmitoy-
lation-myristoylation-linked single A206K eGFP construct
value (Fig. 2D). The tandem was, therefore, identified as corre-
sponding to a dimer.
Regulation of the Oligomeric State of the EGFR Can Be Deter-
mined by SpIDA—To assess the capacity of SpIDA to monitor
potential ligand-induced alteration in oligomeric organization
of a transmembrane protein, we selected the single transmem-
brane pass EGFR. After the addition of A206K eGFP to the
P-M-A206K eGFP P-M-2xA206K eGFP
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FIGURE 1.Regulated expression patterns of palmitoylation-myristoylation-linked forms of A206K eGFP. Flp-InTM T-RExTM 293 cell lines harboring either
palmitoylation-myristoylation-linked A206K eGFP (P-M-A206K eGFP) (A, left) or an equivalent palmitoylation-myristoylation-linked form of the A206K eGFP
tandem (P-M-2xA206K eGFP) (A, right) were induced to express these constructs by treatment with doxycycline (100 ngml1, 24 h). Confocal images identify
their plasma membrane delivery. Scale bar, 10 m. B, lysates of cells that had been treated with the indicated concentration of doxycycline for 24 h were
resolved by SDS-PAGE and immunoblottedwith an anti-GFP antiserum. C, confocal images of the basolateral surface of such cells are shown. Scale bar, 10m.
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carboxyl-terminal tail of the full-length receptor, this construct
was also used to generate stable Flp-InTM T-RExTM 293 cells in
which expression of the construct was under doxycycline-in-
ducible control. It is well established that binding of EGF pro-
motes or stabilizes dimerization of the receptor (5) (Fig. 3A). To
assess the extent of this, following doxycycline-induced expres-
sion of EGFR-A206K eGFP, cells were treated with or without
100 nM EGF for 10 min at 37 °C. Cell lysates were then gener-
ated and applied to non-denaturing blue native polyacrylamide
gels, either with or without the preaddition of SDS to disrupt
non-covalent associations. Subsequent immunoblotting dem-
onstrated that in the absence of EGF, virtually all of the EGFR-
A206K eGFP construct was monomeric (Fig. 3B). However,
treatment with EGF resulted in a substantial proportion of the
receptor constructmigrating as a larger complex (Fig. 3B). This
was not a reflection of a covalentmodification because the addi-
tion of SDS to such samples prior to resolution on the blue
native polyacrylamide gel resulted in all of the receptor migrat-
ing as amonomer (Fig. 3B). As for the palmitoylation-myristoy-
lation motif-linked form of A206K eGFP, varying amounts of
EGFR-A206K eGFP were present in the stable Flp-InTM
T-RExTM 293 cells after treatment with differing concentra-
tions of doxycycline (Fig. 3C). SpIDA analysis of EGFR-A206K
eGFP organization in the basolateral membrane indicated that
in the absence of EGF, the EGFR-A206K eGFP construct was
present largely as a monomer (Fig. 3D). The addition of 100 nM
EGF resulted in rapid interactions, such that within 10 min,
some 75% of the construct was now dimeric (Fig. 3D). Applica-
tion of a range of concentrations of EGF demonstrated that this
conversion frommonomer to dimer was concentration-depen-
dent with EC50 2.99 0.07 nM (Fig. 3D).
The Human 5-HT2C Receptor Labeled at Its Carboxyl Termi-
nus with A206K eGFP Is Functional andAble to Bind a Selective
Antagonist with High Affinity—The serotonin 5-HT2C receptor
is a well studiedmember of the family of rhodopsin-like GPCRs
(31) and is the molecular target of lorcaserin HCl, recently
approved by the Federal Drug Administration as BELVIQ, a
medicine for chronic weight management (32). The 5-HT2C
receptor has been described, based on analysis of data obtained
from fluorescence correlation spectroscopy (FCS), to exist as a
strict dimer at various expression levels (33). We expressed
human 5-HT2C-A206K eGFP stably at the Flp-InTM T-RExTM
locus of Flp-InTMT-RExTM293 cells and induced varying levels
of this construct by treatment with a range of concentrations of
doxycycline (Fig. 4). This was assessed qualitatively via immu-
noblotting studies (Fig. 4A) and quantified by measuring either
the specific binding of [3H]mesulergine, a high affinity antago-
nist of the 5-HT2C receptor (Fig. 4B), or simply by measuring
fluorescence emission of A206K GFP (Fig. 4C). These two
parameters provided equivalent information on relative and
absolute expression levels because they were highly correlated
(Fig. 4D). Expressed 5-HT2C-A206K eGFP was functional. The
addition of 5-HT to cells induced to express the receptor con-
struct resulted in a large, concentration-dependent, increase in
[Ca2]i thatwas antagonized, in a surmountablemanner, by the
co-addition of the highly selective 5-HT2C receptor antagonist
SB242084 (Fig. 4E).
The Oligomeric State of the 5HT2C Receptor Analyzed by
SpIDA—As anticipated for a transmembrane receptor,
5-HT2C-A206K eGFP was also effectively delivered to the cell
surface when expression was induced in this cell line (Fig. 5, A
and B). QB analysis of 5-HT2C-A206K eGFP, 23.52  0.92 IU
(mean S.E., n 192), did not vary statistically across a range
of expression levels (Fig. 5C), and the average QB of 5-HT2C-
A206K eGFP across the full data set was close to twice (1.85
0.21 times, mean  S.E., n  192) that of the palmitoylation-
myristoylation-linked single A206K eGFP (Fig. 5C). These data
would be consistent, as argued previously (33), with the
5-HT2C-A206K eGFP construct being, predominantly, a con-
stitutive dimer over a range of expression levels. However, QB
in different RoIs expressing 5-HT2C-A206K eGFP displayed a
substantial range, although the data fit for individual RoIs was
routinely excellent (Fig. 6). This suggested amore complex pat-
tern than for the palmitoylation-myristoylation-linked forms of
A206K eGFP. In RoIs from cells expressing the 5-HT2C-A206K
eGFP construct, and in cells expressing the palmitoylation-
myristoylation-linked forms of A206K eGFP, visual inspection
and quantification of the images showed a wide range of fluo-
A
0
50
100
150
250
200
300
O
cc
ur
en
ce
350
0
50
100
150
250
200
300
O
cc
ur
en
ce
350
Intensity (IU)
Quantal 
Brightness = 13
P-M-A206K eGFP 
Quantal 
Brightness = 26
P-M-2xA206K eGFP 
B
0 500 1000 1500 2000 2500 3000 3500
Intensity (IU)
0 500 1000 1500 2000 2500 3000 3500
C D
1001052.51.25 1001052.51.25
0
5
10
15
20
25
30
Q
ua
nt
al
 b
rig
ht
ne
ss
 (I
U
)
0
5
10
15
20
25
30
Q
ua
nt
al
 b
rig
ht
ne
ss
 (I
U
)
(44) (44) (44) (44) (44)
(44) (44) (44) (44) (44)
FIGURE 2.Quantal brightness analysis of palmitoylation-myristoylation-
linked forms of A206K eGFP. QB analysis was performed on images from
RoIs of thebasolateral surfaceof cells induced toexpress different amounts of
palmitoylation-myristoylation-linked A206K eGFP (A) or the palmitoylation-
myristoylation-linked A206K eGFP tandem (B). Specific RoIs (highlighted
squares) and their associated intensity histograms are shown for illustrative
purposes. 44 distinct RoIs were analyzed for each doxycycline concentration.
No difference in QB was observed for palmitoylation-myristoylation-linked
A206K eGFP at different doxycycline concentrations; therefore, these values
werepooled toprovideQB12.710.29 (mean S.E.,n220) (broken line)
for this construct (C). QB values (24.98  0.53, mean  S.E. (error bars), n 
220) were also assessed for the palmitoylation-myristoylation-linked A206K
eGFP tandem at different doxycycline concentrations (D). Twice QB of palmi-
toylation-myristoylation-linked A206K eGFP is noted as the broken line in D.
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rescence intensity values across the RoIs examined. To explore
thismore fully, we analyzed initially themeasuredQBvalues for
each RoI taken from cells expressing the palmitoylation-myris-
toylation-linked single A206K eGFP and plotted these individ-
ually. Even following treatment with a single concentration of
doxycycline, which, conceptually, should result in equivalent
expression of the construct in each cell, a wide range of fluores-
cence intensity values were measured for different RoIs (Fig.
7A). Despite this variation in fluorescence intensity values, the
average QB value did not vary and was consistent with palmi-
toylation-myristoylation-linked single A206K eGFP being a
monomer in all locations and across the range of expression
levels achieved (Fig. 7B). Similar analysis of the data from the
palmitoylation-myristoylation-linked A206K eGFP tandem
showed once again across the range of fluorescence intensity
values measured in different RoIs that this construct was iden-
tified as dimeric (Fig. 7, A and B). In contrast, detailed analysis
of cells andRoIs expressing the 5-HT2C-A206K eGFP construct
showed a very different pattern (Fig. 7C). Here, when plotting
QB from RoIs of varying fluorescence intensity, the predomi-
nant signal varied substantially. In regionsof lower average fluo-
rescence intensity, QB values were consistent with the receptor
being predominantly monomeric with some indication of a
proportion of dimers (Fig. 7C). However, within RoIs of sub-
stantially higher average fluorescence intensity, the QB signals
were largely consistent with dimers and oligomeric entities
(Fig. 7C). Quantification, inwhichQB values greater thanmean
dimer 3 S.E. valueswere considered to represent oligomer-
ic forms, indicated that in RoIs with average fluorescent inten-
sity 1500, the percentage of oligomers was 5.8%, whereas in
RoIs with average fluorescent intensity1500, the proportion
of oligomeric forms was markedly higher at 48.9% (Fig. 7C).
The Effect of Antagonist Treatment upon theOligomeric State
of 5-HT2C—We finally explored potential effects of ligands that
act as antagonists/inverse agonists of the 5-HT2C receptor,
including SB242084, on receptor quaternary organization. In
ligand binding studies performed on membranes generated
from Flp-InTM T-RExTM 293 cells induced to express 5-HT2C-
A206K eGFP, SB242084was able to compete fullywith [3H]me-
sulergine to bind to the receptor construct (Fig. 8A), with Ki
estimated as 2.3 nM. Two further 5-HT2C receptor blockers, the
highly structurally related antagonist SB243213 (Ki  2.1 nM)
and RS102221 (Ki  16.6 nM), from a very distinct chemical
series, were also able to fully outcompete [3H]mesulergine to
bind the receptor construct (Fig. 8, B andC). Treatment of cells
expressing 5-HT2C-A206K eGFP with SB242084 (50 nM, 90
min, 37 °C) before imaging of the basolateral membrane and
SpIDA analysis resulted in amarked alteration inmeasuredQB
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values. There was a large, statistically highly significant, reduc-
tion in average QB of 5-HT2C A206K eGFP, to 1.46 0.12-fold
(mean  S.E., n  48) that of the palmitoylation-myristoyla-
tion-linked singleA206K eGFP construct value (Fig. 9A).More-
over, equivalent treatment of cells with either SB243213 (50
nM) or RS102221 (100 nM) also resulted in very similar out-
comes (Fig. 9A). Fluorescence intensity of the RoI is directly
related to the number of molecules of the fluorophore imaged.
Detailed analysis of QB values with fluorescence intensity of
individual RoIs was consistent with the predominant form of
antagonist-bound 5-HT2C-A206K eGFPbeing amonomer (Fig.
9B), and once more, this feature was most marked in RoIs of
lower fluorescence intensity (Fig. 9B). Based on QB values
greater than dimer 3 S.E. in RoIs with average fluorescent
intensity 1500, now only 3.3% of 5-HT2C A206K eGFP was
oligomeric. Furthermore, even in RoIs with average fluorescent
intensity1500, the proportion of oligomeric species was only
7.3% (Fig. 9B). The effect of SB242084was time-dependent (Fig.
9C), with half-maximal effect produced with 30 min (Fig. 9C).
To examine the reversibility of this effect, cells expressing
5-HT2C-A206K eGFP were treated with SB242084 (50 nM),
SB243213 (50 nM), or RS102221 (100 nM) for 90 min, and the
antagonist-containing medium was then removed. The cells
were washed six times in growth medium and incubated for 60
min at 37 °C. Imaging of the basolateral membrane and SpIDA
analysis of these images revealed a recovery of the average QB
values for 5-HT2C-A206K eGFP to a level not significantly dif-
ferent from the untreated cells (Fig. 9A).
DISCUSSION
Analysis of the quaternary organization of GPCRs within the
predominant rhodopsin-like or class A grouping has employed
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a wide range of approaches (34, 35). Despite many years of
study, conclusions remain both uncertain and contentious.
These range from views that such receptors are predominantly
monomeric and have little potential to interact in more than a
fleeting fashion (17–20) to those that posit that the receptors
are predominantly dimeric (22–23) or even tetrameric (3, 24)
and that such organizational structure is relatively stable. In an
attempt to address this issue, herein we have employed SpIDA.
SpIDAis abiophysical technique inwhichpixel-integrated fluo-
rescence intensity histograms are generated from RoIs defined
from confocal laser scanning microscopy images of cells
expressing fluorophore-tagged or modified proteins (8–9).
Histograms of the total number of pixels for each integrated
fluorescence intensity value, within the selected RoI excited by
the laser, are constructed and analyzed by super-Poissonian
distribution functions to obtain density maps and QB values of
the fluorophore-tagged protein. The distribution of the histo-
gram provides information about the number and oligomeriza-
tion state(s) of the tagged protein (8, 9).
Preliminary data for subsequent analysis of the oligomeriza-
tion state of the 5-HT2C receptorwere provided by two separate
studies. In the first, we used a co-translational/post-transla-
tional palmitoylation-myristoylation sequence from the Lyn
non-receptor tyrosine kinase to anchor either a singlemolecule
of A206K eGFP or a tandem of this protein directly to the
plasma membrane of cells. These constructs were expressed
from the doxycycline-regulated Flp-InTM T-RExTM locus of
stably transfected Flp-InTM T-RExTM 293 cells to allow varying
amounts of each form to be generated in a controlled fashion.
Importantly, across expression levels, the average QB of palmi-
toylation-myristoylation-linked A206K eGFP was unchanged,
whereas the QB of the palmitoylation-myristoylation-linked
A206K eGFP tandem, although also unchanged at different
expression levels, was almost exactly double. As such, two
linked molecules of A206K eGFP attached to the plasma mem-
brane were identified and quantified as a dimer. Equally impor-
tantly, when measuring the QB of these two constructs across
RoIs in which the average fluorescent intensity varied consid-
erably, the averageQBvalues for these two constructs remained
constant. This implies that even in regions of high fluorescence
intensity and at the highest expression levels produced, there
was no indication of “crowding” or “bystander” effects that gen-
erated artifactual dimers or higher-order complexes. Second,
we took advantage of the well appreciated capacity of many
single transmembrane span receptor tyrosine kinases to
dimerize upon the addition of an agonist ligand to demonstrate
the capacity of SpIDA to detect and quantify such changes. The
addition of EGF to cells induced to express EGFR-A206K eGFP
resulted in SpIDA analyses that indicated a transition from
90% monomer/10% dimer to 20% monomer/80% dimer.
Moreover, these results were similar to those observed by
resolving lysates of EGF-treated and untreated cells on non-
denaturing blue native gels. Because we had previously used
SpIDA to demonstrate that the single transmembrane domain
axonal guidance receptor Robo-1 is a constitutive dimer (12),
we confirmed SpIDA as a valid approach to assess the quater-
nary organization of a variety of transmembrane proteins,
including, potentially, seven-transmembrane domain GPCRs.
For these studies, we selected the 5-HT2C receptor. This
selection was based on previous work that employed confocal
FRET acceptor bleaching and FCS in combination with photon
counting histogram analysis to conclude that this receptor is a
strict dimer across a broad range of expression levels (33, 36).
Averaging of QB values across all of the RoIs examined on cells
induced to express 5-HT2C-A206K eGFP was generally consis-
tent with the concept of this receptor being a constitutive
dimer. However, unlike the situation with either the palmitoy-
lation-myristoylation-linked single A206K or the palmitoyla-
tion-myristoylation-linked A206K eGFP tandem where QB
and, therefore, estimated organization stoichiometry did not
vary significantly with the fluorescence intensity of the RoI
studied, this did vary markedly for the 5-HT2C-A206K eGFP
construct. Although the average QB across the full data set
could be interpreted as the receptor being present entirely as
constitutive dimers, this conclusion was invalid and was poten-
tially much more complex when analyzed selectively in RoIs of
differing intensity. In RoIs of modest average fluorescence
intensity, QB values of 5-HT2C-A206K eGFP were consistent
with the receptor being predominantly monomeric, with a
small proportion of dimers, whereas in RoIs of higher average
fluorescence intensity, the proportion of monomers was much
reduced, and the proportion of dimers and higher-order com-
plexes was substantial. It is interesting to compare these results
and conclusions with studies from Calebiro et al. (37) on the
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quaternary structure of the 1- and 2-adrenoceptors. Here,
using a transient transfection approach, incorporation of fluo-
rophores into SNAP-tagged (38) forms of these receptors, and
single molecule tracking, these workers concluded that the
number and proportion of receptor oligomers increased with
expression level and that at similar expression levels, the2-ad-
renoceptor was more likely to be oligomeric than the 1-adre-
noceptor (37). These results are similar to themixture ofmono-
mers, dimers, and higher-order forms of the 5-HT2C receptor
observed herein.Moreover, although a number of studies based
on single molecule tracking support the concept that class A
GPCRs can interact, in a number of cases, such interactions
appear to be short term and dynamic (17, 39) rather than fixed
and static (22, 23).
Previous work on the oligomerization state of the 5-HT2C
receptor by Herrick-Davis and colleagues (22, 23, 33) has cen-
tered onusing repetitive, single illumination FCS spotmeasure-
ments. FCS is particularly well suited for studying fluorescent
molecules, which freely diffuse via Brownian motion in a uni-
form fashion through space and time within the detection vol-
ume (i.e. isotropic diffusion). Different sized receptor oligomer
species slowly diffuse at varying rates (0.1–1 m2/s), so this
approach is potentially less well suited for detecting receptor
oligomer species that move at varying rates in space over time
within the detection volume (i.e. anisotropic diffusion). A fur-
ther potential concern with analysis of FCS is photobleaching
and cell movement. Photobleaching is common for fluorescent
membrane proteins, due to their two-dimensional confinement
within the plasma membrane, even if the laser intensity has
been minimized. Initial FCS spot scan measurements are par-
ticularly prone to photobleaching (40). This is a particular issue
with the initial scan, as noted byHerrickDavis et al. (33). There-
fore, in their studies, the average molecular brightness was
quantified using only observation spot scans 2–10. This initial
apparent bleaching and its subsidence can be attributed to
complete bleaching of slow moving/immobile oligomeric pro-
tein species (40) andmay limit the ability of FCS to observe such
slow moving/immobile oligomeric protein species. This would
make them invisible during subsequent scan acquisition. This
may contribute to the lack of detection of higher-order com-
plexes reported in previous work (22, 33). In part, SpIDA was
developed to overcome the FCS detection limitation issues
described above. SpIDA is very well suited for detecting recep-
tor oligomer species, which are immobile or move slowly at
varying diffusion rates, and analysis via SpIDA is potentially
more informative and accurate than FCS. Furthermore, SpIDA
requires only a single input image acquired at a 12.8-s dwell
time/pixel on the collected image frame to quantify molecular
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brightness, so underestimation of molecular brightness due to
photobleaching is negligible.
It was particularly interesting in the current studies that
treatment of cells expressing 5-HT2C-A206KeGFPwith ligands
that are antagonists/inverse agonists at this receptor resulted in
a marked reduction in the overall organizational size of the
receptor population. Treatment with three distinct antagonists
produced data consistent with the receptor being predomi-
nantlymonomeric in the presence of these ligands. The issue of
whether class A GPCR quaternary structure is altered in the
presence of ligands has been as controversial as the overarching
questions on their quaternary organization in the basal state
(27, 41). At least for the 5-HT2C receptor, the current results
provide a clear answer for a group of antagonists. This is also of
interest in terms of approach because a number of efforts to
employ singlemolecule tracking ofGPCRs to define quaternary
organization, particularly for muscarinic acetylcholine recep-
tor subtypes, have used fluorescently labeled antagonist ligands
to label the receptor (17, 42). This relies on the basic assump-
tions that the ligands bind the receptors with a defined 1:1 stoi-
chiometry and that ligand binding does not inherently alter
quaternary structure. Although this now needs to be explored
for other members of the class A GPCR family, including the
muscarinic receptor subfamily, it is clearly not the case for the
5-HT2C receptor.
In an attempt to define the basis for homomeric 5-HT2C
receptor interactions, Mancia et al. (43) introduced cysteine
residues into a variety of locations within the transmembrane
domains of the rat 5-HT2C receptor. These variants were then
employed in cross-linking studies. Interactions were observed
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that implicated residues in transmembrane domain I in form-
ing a dimeric interaction. Moreover, a second potential inter-
face involving residues within transmembrane domains IV and
V was also identified. These results suggest that either there is
more than one way to produce a class A receptor dimer (44) or
that, as shown recently for other receptors, including the 1b-
adrenoceptor (45) and the muscarinic M3 acetylcholine recep-
tor (3, 46), higher-order oligomers can form. Future studies will
consider the quaternary organization of a number of the
mutants generated by (43).
To date, studies on GPCR organization have been largely
restricted to the use of transfected cell systems. Although it has
been possible to predict the presence of certain heteromeric
GPCR complexes directly in vivo via analysis of behavioral phe-
notypes of mouse knock-out models and their recovery follow-
ing replacement with, for example, a virally delivered construct
(47), equivalent studies are not practical for homomeric com-
plexes. However, studies employing either a chemical biology
approach (48) or homogeneous time-resolved FRET-based
labeling of receptor agonists and antagonists (49) have allowed
ex vivo analysis of the presence of such receptor homomers.
Although impressive, such studies have not yet been able to
provide insight into the proportion of a receptor that is homo-
meric. Because SpIDA requires only confocal images of suitably
labeled cells and tissues and is compatible with chemically fixed
tissues, studies on knock-in lines of mice in which the receptor
is modified with a suitable, monomeric fluorophore, such as
A206KeGFP,may soon allow this issue to be addressed directly.
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